1. GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA. (June 2017) Authors: Karmali, R.; Chukkapalli, V.; Pro, B.; Borgia, J.A.; Mazar, A.; Ugolkov, A.; Giles, F.J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. METABOLIC CHANGES ASSOCIATED WITH METFORMIN POTENTIATES ANTI‐BCL‐2 INHIBITOR, ABT‐199, AND CDK9 INHIBITOR, BAY‐1143572 AND REDUCES VIABILITY OF LYMPHOMA CELLS. (June 2017) Authors: Karmali, R.; Chukkapalli, V.; Gordon, L.I.; Borgia, J.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗